Home/Filings/4/0000885590-11-000086
4//SEC Filing

Pearson J. Michael 4

Accession 0000885590-11-000086

CIK 0000885590other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 11:03 AM ET

Size

5.5 KB

Accession

0000885590-11-000086

Insider Transaction Report

Form 4
Period: 2011-12-23
Pearson J. Michael
DirectorChief Executive Officer
Transactions
  • Tax Payment

    Common Shares, no par value

    2011-12-2350,9976,144,142 total
Footnotes (2)
  • [F1]This number represents common shares withheld from the issuance of common shares to the Reporting Person to satisfy the tax withholding obligations due upon vesting of Matching Restricted Share Units.
  • [F2]This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1. This number includes shares underlying equity awards previously reported as withheld to cover tax withholding obligations due on PSUs settled in error in February and April 2011 and subsequently restored.

Issuer

Valeant Pharmaceuticals International, Inc.

CIK 0000885590

Entity typeother

Related Parties

1
  • filerCIK 0001426004

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 11:03 AM ET
Size
5.5 KB